1. Papke, Prog. in Neurobio., 1993. 41: p. 509-531.

2. Clarke, Biochem. Soc. Sym., 1994. 59: p. 83-95.

3. Adler, et al., Biol. Psych., 1992. 32(7): p. 607-616.

4. Leonard, et al., in Society for Neuroscience. 1993.

5. Arneric, et al., in Psychopharmacology: The Fourth Generation of Progress, F. Bloom and D.J. Kupfer, Editor. 1995, Raven Press: New York. p. Chapter 9.

6. Stolerman, et al., Trends Pharmacol. Sci., 1991. 12: p. 467„473.

7. Stolerman, in Handbook of Psychopharmacology, S.D. Iversen, L.L. Iversen, andS.H. Snyder, Editor. 1987, Plenum Press: N.Y. p. 421-465.

8. Papke, et al., J. Pharmacol. Exp. Ther., 1994. 268: p. 718-726.

9. Rose, et al., in International Symposium on Nicotine: The Effects of Nicotine on Biological Systems II. 1994. Montreal, Canada: Birkhauser Verlag.

10. de Fiebre, et al., Mol. Pharmacol., 1995. 47: p. 164-171.

11. Taglialatela, et al., Biophys. J., 1992. 61.

12. Costa, et al., Biophys. J., 1994. 67(1): p. 395-401.

13. McGehee, et al., Science, 1995. 269: p. 1692-1696.

14. Klein, et al., J. Neurochem., 1992. 58(3): p. 870-876.

15. Zhang, et al., Neuron, 1994. 12: p. 167-177.

16. Alkondon, et al., J. Pharmacol. Exp. Ther., 1993. 265(3): p. 1455-1473.